Paul W. Hoelscher
2021
Compensation breakdown
| Non-Equity Incentive Plan | $1,215,500 |
|---|---|
| Salary | $650,653 |
| Stock Awards | $5,272,731 |
| Other | $204,773 |
| Total | $7,343,656 |
Hoelscher received $5.3M in stock awards, accounting for 72% of the total pay in 2021.
Hoelscher also received $1.2M in non-equity incentive plan, $650.7K in salary and $204.8K in other compensation.
Rankings
In 2021, Paul W. Hoelscher's compensation ranked 1,628th out of 12,397 executives tracked by ExecPay. In other words, Hoelscher earned more than 86.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,628 out of 12,397 | 87th |
Division Manufacturing | 593 out of 5,492 | 89th |
Major group Chemicals And Allied Products | 221 out of 2,367 | 91st |
Industry group Drugs | 185 out of 2,090 | 91st |
Industry Pharmaceutical Preparations | 123 out of 1,537 | 92nd |
Pay ratio
| Paul W. Hoelscher's Pay | $7,343,656 |
|---|---|
| Median Employee's Pay | $298,200 |
| Pay Ratio | 25to 1 |
In 2021, the annual total compensation of Paul W. Hoelscher was $7,343,656.
The annual total compensation of the median employee at Horizon Pharma was $298,200.
The ratio of Paul W. Hoelscher's pay to the pay of median employee was therefore 25 to one.
Hoelscher's colleagues
We found five more compensation records of executives who worked with Paul W. Hoelscher at Horizon Pharma in 2021.
2021
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2021
Barry Moze
Horizon Pharma
Chief Administrative Officer
2021
Brian Beeler
Horizon Pharma
General Counsel
2021
Andy Pasternak
Horizon Pharma
Executive Vice President, Chief Strategy Officer
2021
Jeffrey FACP
Horizon Pharma
Chief Medical Officer
News
March 17, 2022
March 17, 2021
March 18, 2020
April 8, 2019